109 related articles for article (PubMed ID: 9295064)
1. N-acetylation polymorphism in Japanese patients with sarcoidosis.
Asada M; Goto H; Abe M; Tachibana T; Suzuki Y; Suzuki T
Pharmacogenetics; 1997 Aug; 7(4):341-4. PubMed ID: 9295064
[No Abstract] [Full Text] [Related]
2. N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.
Hamasaki T; Inatomi H; Katoh T; Aono H; Ikuyama T; Muratani T; Matsumoto T
Int J Urol; 2003 Mar; 10(3):167-73. PubMed ID: 12622714
[TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
[TBL] [Abstract][Full Text] [Related]
4. Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer.
Shibuta K; Nakashima T; Abe M; Mashimo M; Mori M; Ueo H; Akiyoshi T; Sugimachi K; Suzuki T
Cancer; 1994 Dec; 74(12):3108-12. PubMed ID: 7982175
[TBL] [Abstract][Full Text] [Related]
5. An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction.
Abe M; Suzuki T; Deguchi T
Jpn J Hum Genet; 1993 Jun; 38(2):163-8. PubMed ID: 8102908
[TBL] [Abstract][Full Text] [Related]
6. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese.
Inatomi H; Katoh T; Kawamoto T; Matsumoto T
Int J Urol; 1999 Sep; 6(9):446-54. PubMed ID: 10510890
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer.
Shibuta J; Eto T; Kataoka A; Inoue H; Ueo H; Suzuki T; Barnard GF; Mori M
Am J Gastroenterol; 2001 Dec; 96(12):3419-24. PubMed ID: 11774959
[TBL] [Abstract][Full Text] [Related]
8. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.
Doll MA; Fretland AJ; Deitz AC; Hein DW
Anal Biochem; 1995 Nov; 231(2):413-20. PubMed ID: 8594994
[TBL] [Abstract][Full Text] [Related]
9. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
[TBL] [Abstract][Full Text] [Related]
10. The N-acetyltransferase (NAT) gene: an early risk marker for diabetic nephropathy in Japanese type 2 diabetic patients?
Neugebauer S; Baba T; Watanabe T; Ishizaki T; Kurokawa K
Diabet Med; 1994 Oct; 11(8):783-8. PubMed ID: 7851073
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population.
Aynacioglu AS; Cascorbi I; Mrozikiewicz PM; Roots I
Pharmacogenetics; 1997 Aug; 7(4):327-31. PubMed ID: 9295061
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
[TBL] [Abstract][Full Text] [Related]
14. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y
Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413
[TBL] [Abstract][Full Text] [Related]
15. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
Rodriguez JW; Kirlin WG; Ferguson RJ; Doll MA; Gray K; Rustan TD; Lee ME; Kemp K; Urso P; Hein DW
Arch Toxicol; 1993; 67(7):445-52. PubMed ID: 7902079
[TBL] [Abstract][Full Text] [Related]
16. N-acetyltransferase polymorphism among northern Sudanese.
Al-Yahyaee S; Gaffar U; Al-Ameri MM; Qureshi M; Zadjali F; Ali BH; Bayoumi R
Hum Biol; 2007 Aug; 79(4):445-52. PubMed ID: 18075007
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population.
Dhaini HR; Levy GN
Pharmacogenetics; 2000 Feb; 10(1):79-83. PubMed ID: 10739175
[TBL] [Abstract][Full Text] [Related]
19. Study of polymorphic variants C190T, G191A, G857A, and 859Del of the NAT2 gene by the method of restriction fragment length polymorphism.
Nikishina MV; Vavilin VA; Lyakhovich VV
Bull Exp Biol Med; 2008 Oct; 146(4):420-3. PubMed ID: 19489310
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction and its potential as a pharmacokinetic tool.
Heim MH
Clin Pharmacokinet; 1992 Nov; 23(5):321-7. PubMed ID: 1362142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
